HT
AKBA icon

HAP Trading’s Akebia Therapeutics AKBA Stock Holding History

HAP Trading’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-36,300
Closed -$4K – 2319
2021
Q1 		$4K Buy
36,300
+5,200
+17% +$18.7K ﹤0.01% 1773
2020
Q4 		$2K Buy
31,100
+4,000
+15% +$11.7K ﹤0.01% 2107
2020
Q3 		$5K Buy
27,100
+11,000
+68% +$96.5K ﹤0.01% 1421
2020
Q2 		$101K Buy
+16,100
New +$167K 0.01% 850
2020
Q1 		– Sell
-10,300
Closed -$26K – 1185
2019
Q4 		$26K Buy
+10,300
New +$49K ﹤0.01% 832
2018
Q1 		– Sell
-10,500
Closed -$8K – 909
2017
Q4 		$8K Buy
+10,500
New +$174K ﹤0.01% 871

Other funds holding AKBA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return